| Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial PD Home, SJ Pocock, H Beck-Nielsen, PS Curtis, R Gomis, M Hanefeld, ... The Lancet 373 (9681), 2125-2135, 2009 | 1758 | 2009 |
| Rosiglitazone evaluated for cardiovascular outcomes—an interim analysis PD Home, SJ Pocock, H Beck-Nielsen, R Gomis, M Hanefeld, NP Jones, ... New England Journal of Medicine 357 (1), 28-38, 2007 | 1056 | 2007 |
| Triglyceride lowering with pemafibrate to reduce cardiovascular risk A Das Pradhan, RJ Glynn, JC Fruchart, JG MacFadyen, ES Zaharris, ... New England Journal of Medicine 387 (21), 1923-1934, 2022 | 401 | 2022 |
| Ендокринологія ПН Боднар, ЮІ Комісаренко, ГП Михальчишин, МІ Бобрик, ... Нова Книга, 2020 | 113 | 2020 |
| Rosiglitazone RECORD study: glucose control outcomes at 18 months PD Home, NP Jones, SJ Pocock, H Beck‐Nielsen, R Gomis, M Hanefeld, ... Diabetic medicine 24 (6), 626-634, 2007 | 112 | 2007 |
| Efficacy and safety of once‐weekly semaglutide versus once‐daily sitagliptin as add‐on to metformin in patients with type 2 diabetes in SUSTAIN China: a 30‐week, double‐blind … L Ji, X Dong, Y Li, Y Li, S Lim, M Liu, Z Ning, S Rasmussen, TV Skjøth, ... Diabetes, Obesity and Metabolism 23 (2), 404-414, 2021 | 67 | 2021 |
| Linagliptin as add‐on to empagliflozin and metformin in patients with type 2 diabetes: two 24‐week randomized, double‐blind, double‐dummy, parallel‐group trials FJ Tinahones, B Gallwitz, M Nordaby, S Götz, M Maldonado‐Lutomirsky, ... Diabetes, Obesity and Metabolism 19 (2), 266-274, 2017 | 63 | 2017 |
| Неалкогольний стеатогепатит у пацієнтів із цукровим діабетом 2-го типу: сучасний погляд на проблему АМ Урбанович Міжнародний ендокринологічний журнал 2, 38-42, 2009 | 24* | 2009 |
| Efficacy and safety of the addition of sitagliptin to treatment of youth with type 2 diabetes and inadequate glycemic control on metformin without or with insulin MY Jalaludin, A Deeb, P Zeitler, R Garcia, RS Newfield, Y Samoilova, ... Pediatric Diabetes 23 (2), 183-193, 2022 | 22 | 2022 |
| A randomized trial evaluating the efficacy and safety of fast-acting insulin aspart compared with insulin aspart, both in combination with insulin degludec with or without … WS Lane, E Favaro, N Rathor, HC Jang, MIS Kjærsgaard, A Oviedo, ... Diabetes Care 43 (8), 1710-1716, 2020 | 22 | 2020 |
| EFFECTS OF NITROSATIVE STRESS AND REACTIVE OXYGEN O Zayachkivska, M Gzregotsky, M Ferentc, A Yaschenko, A Urbanovych Journal of physiology and pharmacology 59 (2), 77-87, 2008 | 22 | 2008 |
| Adropin in women with polycystic ovary syndrome J Kuliczkowska-Płaksej, A Mierzwicka, M Jończyk, B Stachowska, ... Endokrynologia Polska 70 (2), 151-156, 2019 | 20 | 2019 |
| Adipose tissue hormones and their clinical significance AM Urbanovych Endocrinology 18 (1), 69-72, 2013 | 20* | 2013 |
| Polycystic ovary syndrome in every day practice AM Urbanovych Int J Endocrinol 14 (1), 40-45, 2018 | 17* | 2018 |
| Genome diversity in Ukraine TK Oleksyk, WW Wolfsberger, AM Weber, K Shchubelka, OT Oleksyk, ... GigaScience 10 (1), giaa159, 2021 | 16 | 2021 |
| Роль лептину у патогенезі захворювань, які супроводжуються інсулінорезистентністю АМ Урбанович Експериментальна та клінічна фізіологія і біохімія, 57-62, 2010 | 16* | 2010 |
| Selected CNR1 polymorphisms and hyperandrogenemia as well as fat mass and fat distribution in women with polycystic ovary syndrome D Jędrzejuk, Ł Łaczmański, J Kuliczkowska, A Lenarcik, A Trzmiel-Bira, ... Gynecological Endocrinology 31 (1), 36-39, 2015 | 14 | 2015 |
| The Content of Blood Leptin and Activity of Systemic Inflammatory Response in Patients with Type 2 Diabetes Mellitus depending on Weight and Length of the Process. B MANKOVSKY, A URBANOVYCH International Journal of Physiology and Pathophysiology 6 (3), 213-219, 2015 | 14* | 2015 |
| Simvastatin and Omega-Polyunsaturated Fatty Acids in the Treatment of Cardiomyopathy in Type 2 Diabetes Mellitus Patients V Serhiyenko, A Urbanovich, A Serhiyenko, V Segin, L Serhiyenko Atherosclerosis (Supplements)(Component) 1 (9), 203, 2008 | 13 | 2008 |
| Діабетична автономна нейропатія серця (патогенез, діагностика, лікування) ОО Сергієнко Львів: Атлас, 1999 | 13* | 1999 |
Philip HomeProfessor of Diabetes Medicine, Newcastle University在 ncl.ac.uk 的电子邮件经过验证
